Crescent Biopharma, Inc.

CBIO·NasdaqCM
Compare
14.46−0.45 (−3.02%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours14.460.00 (0.00%)Oct 12, 4:01 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close14.91
Open14.79
Day range14.3215.09
52-week range8.7227.41
Off day high−4.17%
Off 52-week high−47.25%
Volume153.89K
Avg. volume (3M)399.88K
Market cap537.14M
EPS (TTM)-7.63
Forward P/E-5.50
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding37.14M
Short interest—
Earnings date—
Analyst target—
Profit margin—

Against its peers

Compare in full ›
CBIO PBYI CGEM BBOT NBP CHRS
Market cap 537.14M 531.17M 918.80M 261.37M 153.12M 159.14M
P/E (TTM) — 20.2 — — — —
Forward P/E -5.5 29.4 -5.9 -1.2 -1.2 -1.6
Price/book 3.0 3.8 3.0 0.8 0.8 2.6
Dividend yield — — — — — —
1-year change +45.46% +94.52% +98.34% −70.31% −75.91% −38.15%
Today −3.02% 0.00% −3.73% −1.51% −5.38% −3.74%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Crescent Biopharma's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Puma Biotechnology, Inc.PBYI · Biotechnology 531.17M 10.29 0.00%
Cullinan Therapeutics, Inc.CGEM · Biotechnology 918.80M 14.95 −3.73%
BridgeBio Oncology Therapeutics, Inc.BBOT · Biotechnology 261.37M 3.2600 −1.51%
NovaBridge BiosciencesNBP · Biotechnology 153.12M 1.3200 −5.38%
Coherus Oncology, Inc.CHRS · Biotechnology 159.14M 1.0300 −3.74%
Pyxis Oncology, Inc.PYXS · Biotechnology 240.11M 2.0100 −0.99%
Compass Therapeutics, Inc.CMPX · Biotechnology 168.83M 0.9375 −5.59%
Biohaven Ltd.BHVN · Biotechnology 1.78B 11.81 −2.24%

Healthcare companies of a similar market value (546.06M).

Company Mkt cap Price Today
CytomX Therapeutics, Inc.CTMX · Biotechnology 527.32M 2.4200 −5.84%
Aclaris Therapeutics, Inc.ACRS · Biotechnology 529.92M 3.6000 −6.01%
BlossomHill Therapeutics, Inc.BLSM · Biotechnology 548.93M 17.27 −1.20%
Puma Biotechnology, Inc.PBYI · Biotechnology 531.17M 10.29 0.00%
Electra Therapeutics, Inc.ETRA · Biotechnology 584.99M 9.32 +3.10%
REGENXBIO Inc.RGNX · Biotechnology 512.92M 7.77 −3.72%
Delcath Systems, Inc.DCTH · Medical Devices 543.73M 15.67 +2.02%
Valneva SEVALN · Biotechnology 562.30M 5.93 +2.60%

Also based in Waltham, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Thermo Fisher Scientific Inc.TMO · Waltham, MAOdds 244.86B 662.24 +0.64%
Veralto CorporationVLTO · Waltham, MA 23.94B 98.20 +1.31%
Revvity, Inc.RVTY · Waltham, MA 17.36B 155.61 +0.93%
Repligen CorporationRGEN · Waltham, MA 10.95B 172.51 −0.79%
Spyre Therapeutics, Inc.SYRE · Waltham, MA 8.03B 85.90 +0.25%
Pegasystems Inc.PEGA · Waltham, MA 5.74B 34.91 −2.08%
Cogent Biosciences, Inc.COGT · Waltham, MA 5.17B 29.78 −3.94%
Dyne Therapeutics, Inc.DYN · Waltham, MA 2.98B 15.96 −4.09%

The stocks whose daily moves over the past year went most closely with Crescent Biopharma's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
ORIC Pharmaceuticals, Inc.ORIC · Correlation 0.31 1.22B 11.81 −1.50%

What visitors to Crescent Biopharma's page also look at.

Company Mkt cap Price Today
Benitec Biopharma Inc.BNTC 316.39M 9.07 +2.25%
Akari Therapeutics PlcAKTX 19.52M 8.54 −2.62%
Pulmatrix, Inc.PULM 5.22M 1.4300 −2.05%
Cellectar Biosciences, Inc.CLRB 13.52M 1.4300 −1.38%
Calithera Biosciences, Inc.CALA 487 0.0001 0.00%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All CBIO news ›
Stock Titan·Positive

Crescent Biopharma Announces Grants of Inducement Awards

The employee options carry a $13.94 exercise price and vest subject to continued service. Crescent Biopharma (CBIO) approved inducement options covering 81,525 ordinary shares for six non-executive employees on October 5, 2026. Options for…

Grafa·Positive

Crescent receives FDA clearance for CR-002 trial

Assets related to this article Crescent Biopharma (NASDAQ:CBIO) received FDA clearance for its Investigational New Drug application for CR-002, an antibody-drug conjugate being developed for advanced solid tumors. CR-002 is designed to…

From articles in the 4Search news index.

In the news

7mentions in 30 days
4with it in the headline
Positivesentiment

Mentioned with

Compensation Committee6Crescent6Crescent Biopharma, Inc.6U.S. Food and Drug Administration3Astrazeneca2Daiichi Sankyo2Definium Therapeutics2Eli Lilly2

People in the coverage

Crescent Biopharma6Carroll5Akebia2Alan H. Auerbach2Anand Parikh2Boehringer Ingelheim2

Themes

Announces6Grants5Inducement5Waltham5Biopharma4Crescent4Awards3Mass.3

Most coverage from

  1. stocktitan.net2
  2. bostonherald.com1
  3. grafa.com1
  4. manilatimes.net1
  5. marketscreener.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.